Long Corridor Asset Management LTD Bei Gene, Ltd. Transaction History
Long Corridor Asset Management LTD
- $129 Million
- Q1 2025
A detailed history of Long Corridor Asset Management LTD transactions in Bei Gene, Ltd. stock. As of the latest transaction made, Long Corridor Asset Management LTD holds 37,000 shares of BGNE stock, worth $8.39 Million. This represents 6.48% of its overall portfolio holdings.
Number of Shares
37,000
Previous 18,400
101.09%
Holding current value
$8.39 Million
Previous $3.4 Million
146.85%
% of portfolio
6.48%
Previous 2.95%
Shares
12 transactions
Others Institutions Holding BGNE
# of Institutions
290Shares Held
40MCall Options Held
111KPut Options Held
112K-
Baker Bros. Advisors LP New York, NY8.8MShares$1.99 Billion23.78% of portfolio
-
Capital International Investors Los Angeles, CA5.09MShares$1.15 Billion0.24% of portfolio
-
Primecap Management CO Pasadena, CA5.06MShares$1.15 Billion0.97% of portfolio
-
Baillie Gifford & CO3.63MShares$823 Million0.74% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.71MShares$615 Million0.09% of portfolio
About BeiGene, Ltd.
- Ticker BGNE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 103,700,000
- Market Cap $23.5B
- Description
- BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...